Together, we can transform the future of cancer care.
Tracking early stage breast cancer with ultrasensitive ctDNA
Information for patients with breast cancer
Monitoring therapy response with ultrasensitive ctDNA across cancer types
Ultrasensitive ctDNA detection in early-stage lung cancer
Personalis is transforming the development of next-generation therapies.
Tell us how Personalis® testing has been part of your story. Your experience could help others understand the difference our testing can make.
What impact did our test(s) have on your care journey?
Did the test result change your doctor’s recommendations?
Media and Publication Consent
We appreciate you sharing your experience with us! Please be aware that information you provide may be used on our website, newsletter, and/or other marketing materials. By clicking here, you consent to us sharing your testimonial and name.
PRO-1287-v1
Notifications
